CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 10 No. 2
 

Oral Morphine Termed Narcotic Standard in Severe Cancer Pain

February 1, 1996

Oral morphine(Drug information on morphine) remains the drug of choice for most patients with severe cancer pain, and the sustained-release form (MS-Contin, Roxanol SR), has certain advantages, Ronald Blum, MD, said at a conference sponsored by Cancer Care, Inc.

Sustained-release morphine has a half-life of from 8 to 12 hours. "You can give it at hour zero and maintain a blood level for 12 hours," said Dr. Blum, deputy director, Kaplan Comprehensive Cancer Center, New York University Medical Center. Morphine sulfate solution has to be given every 4 hours.

Patients can be started directly on sustained-release morphine or can be converted from other opioid narcotic analgesics, he said. "What we tend to do, and what I recommend, is to start out with immediate-release morphine and gradually, over time, as the patient stabilizes, convert to MS Contin."

Since it takes time to reach steady- state concentrations with the sustained-release form, patients should continue to take an immediate-release morphine preparation for several days after starting the sustained-release drug, he said.

Dr. Blum stressed that the enteral route should be used if possible, ie, any access routes to the GI tract (oral, buccal, rectal, tube). Approximately 30 mg of oral morphine is equivalent to 10 mg of injected morphine, he said. Roughly 4 mg of oral hydromorphone(Drug information on hydromorphone) is equivalent to 15 mg of oral morphine.

Methadone(Drug information on methadone) probably should not be used for patients with chronic severe pain, because of the long half-life of the toxic metabolites, Dr. Blum warned. Similarly, meperidine (Demerol), although highly effective when given parenterally at 75 mg for acute pain, is not recommended for the management of chronic pain. The equal oral analgesic dose is 300 mg, which, over time, is associated with a high degree of side effects (primarily sedation).

Fentanyl Patch an Alternative

Dr. Blum singled out fentanyl(Drug information on fentanyl) as a well-tolerated alternative to oral analgesics. Fentanyl is used in the operating room for anesthesia and has been available for a number of years as a transdermal patch (Duragesic). "The problem with fentanyl is that it's very short acting," he said, "but the patch allows continuous release through the skin."

Fentanyl is particularly useful for people who do not have an enteral tract available, or have nausea and vomiting and cannot take oral medication. At about 50 mcg per hour, it is approximately equivalent to 30 mg of morphine by mouth or 10 mg given parenterally, Dr. Blum said.

Because of its slow onset of action, patients should take a short-acting narcotic analgesic while building up their fentanyl dose, he said. "But it does arrive at a steady state and does last from 48 to 72 hours; the patch can be replaced approximately every 3 days ".

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 52-Year-Old Man Presents With an Erythematous Lesion
Cesar Moran, MD , May 22, 2013

A 52-year-old man presented with an erythematous lesion in the axilla of unknown duration. Surgical excision was performed. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Preventing Exposure to Hazardous Drugs
  • Conflicts of Interest in Medicine: What About Ties to Payers?
  • Planning Treatment for Women With Recurrent Epithelial Ovarian Cancer
  • Rising PSA Level in a 46-Year-Old Man
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy